In TCGA, high LYN expression was associated with reduced survival in glioma patients regarding different IDH statuses (p = 0.0454, p = 0.1062, respectively; Figure 3), radiotherapy statuses (p < 0.001, respectively; Figure 3), 1p19q statuses (p < 0.001, p = 0.1533, respectively; Figure 3), and MGMT promotor statuses (p = 0.0074, p < 0.001, respectively; Figure 3). The gene discussed is LYN; the disease is central nervous system cancer.